Clinical Trial Update: Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dabigatran to conventional treatment for preventing silent cerebral infarcts in patients with atrial fibrillation and valvular heart dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Valvular Heart Disease

Drugs mentioned

• Dabigatran (Dabigatran etexilate)

Snippet

Sponsor: Asan Medical Center | Conditions: Atrial Fibrillation, Valve Heart Disease | Phase 4 | Status: COMPLETED